Long-Term Assets: The sum of all assets classified as non-current.
Globeimmune, Inc. (GBIM) had Long-Term Assets of $0.32M for the most recently reported fiscal quarter, ending 2016-03-31.
| Income Statement Financials | |
$0.94M |
|
$-0.86M |
|
$0.51M |
|
$0.43M |
|
$1.80M |
|
$-0.86M |
|
-- |
|
$-0.86M |
|
$-0.86M |
|
$-0.86M |
|
$-0.86M |
|
$-0.86M |
|
$-0.86M |
|
$-0.86M |
|
$-0.84M |
|
5.75M |
|
5.75M |
|
$-0.15 |
|
$-0.15 |
|
| Balance Sheet Financials | |
$9.45M |
|
$0.19M |
|
|
Long-Term Assets |
$0.32M |
$9.77M |
|
$4.14M |
|
-- |
|
$3.48M |
|
$7.62M |
|
$2.15M |
|
$2.15M |
|
$2.15M |
|
5.75M |
|
| Cash Flow Statement Financials | |
$-1.21M |
|
-- |
|
-- |
|
$9.90M |
|
$8.69M |
|
$-1.21M |
|
$0.02M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.28 |
|
-- |
|
-- |
|
-- |
|
-- |
|
45.40% |
|
-91.46% |
|
-91.46% |
|
-- |
|
-91.46% |
|
-91.46% |
|
$-1.21M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
-- |
|
-- |
|
-- |
|
-40.10% |
|
-40.10% |
|
-8.82% |
|
-40.10% |
|
$0.37 |
|
$-0.21 |
|
$-0.21 |
|